Clustering data with hclust algorithm for TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) (Study ST000310)

Peak area negative ion mode (Analysis AN000491)
MetaboliteStructureF1F2
8-methoxy-13-hydroxy-9,11-octadecadienoic acidME1098721.590.41
TG(17:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))[iso3]ME1099461.260.74
PC(13:0/0:0)_1ME1098881.270.73
PE(20:4(5Z,8Z,11Z,14Z)/0:0)ME1098991.270.73
PC(18:2(9Z,12E)/17:2(9Z,11E))_1ME1098961.240.76
DHAME1098801.220.78
PS(17:1(9Z)/22:2(13Z,16Z))_2ME1099251.230.77
Cholic acidME1098771.120.88
PS(19:0/22:2(13Z,16Z))_2ME1099281.150.85
PG(22:0/12:0)ME1099071.140.86
38:5(23Z,26Z,29Z,32Z,35Z)ME1098681.140.86
PC(17:0/10:0)ME1098941.140.86
PS(19:0/22:2(13Z,16Z))_1ME1099271.200.80
PS(17:0/22:0)ME1099221.200.80
PI(14:0/22:2(13Z,16Z))ME1099121.200.80
18-methyl-5Z,8Z,11Z,14Z-nonadecatetraenoic acidME1098651.200.80
(3^-sulfo)Galbeta-Cer(d18:1/22:0(2OH))ME1098591.200.80
PS(17:0/22:1(11Z))ME1099231.180.82
(25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-27-oyl taurineME1098581.160.84
PC(17:2(9Z,12Z)/0:0)ME1098951.170.83
cholesterol sulfateME1098761.170.83
PC(13:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))ME1098911.170.83
PG(14:0/14:0)ME1099061.450.55
PS(15:0/22:2(13Z,16Z))ME1099201.370.63
9-deoxy-9-methylene-PGE2ME1098731.310.69
PI(13:0/22:0)ME1099111.330.67
Palmitic acidME1098861.350.65
PGF2alpha_1ME1099081.340.66
PT(18:0/18:1(9Z))ME1099391.040.96
1,2-ditetradecanoyl-sn-glycero-3-phosphosulfocholineME1098611.050.95
PS(19:1(9Z)/22:2(13Z,16Z))ME1099311.060.94
PS(19:1(9Z)/22:4(7Z,10Z,13Z,16Z))_1ME1099321.060.94
PC(13:0/18:2(9Z,12Z))ME1098901.080.92
PS(21:0/0:0)ME1099341.080.92
Stearic acidME1099401.090.91
PA(22:1(11Z)/22:4(7Z,10Z,13Z,16Z))ME1098851.100.90
PC(10:0/21:0)ME1098871.100.90
PS(13:0/22:0)ME1099171.001.00
PS(19:0/22:4(7Z,10Z,13Z,16Z))_1ME1099291.001.00
PC(15:0/0:0)ME1098921.010.99
PE(O-16:0/20:5(5Z,8Z,11Z,14Z,17Z))ME1099011.020.98
PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))ME1099041.020.98
PI(14:0/22:4(7Z,10Z,13Z,16Z))ME1099130.971.03
PS(17:1(9Z)/22:2(13Z,16Z))_1ME1099240.971.03
PA(22:0/22:4(7Z,10Z,13Z,16Z))ME1098840.991.01
PI(19:0/0:0)ME1099150.981.02
2-methyl-16-heptadecenoic acidME1098670.931.07
PI(12:0/22:2(13Z,16Z))ME1099100.961.04
5,7-Dihydroxy-6-C-methylflavone 7-xylosyl-(1->3)-xylosideME1098700.951.05
DGTS(16:0/18:2(9Z,12Z))ME1098790.951.05
PC(18:2(9Z,12E)/17:2(9Z,11E))_2ME1098970.731.27
(+)-Blennin DME1098570.741.26
PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))ME1099030.741.26
PI(20:4(5Z,8Z,11Z,14Z)/0:0)ME1099160.751.25
PS(19:0/0:0)ME1099260.761.24
17:0 Cholesteryl esterME1098640.891.11
PC(15:0/18:2(9Z,12Z))ME1098930.891.11
12-hydroxy-5Z,8Z,10Z,14Z-Eicosatetraenoic acidME1098620.911.09
1-(8-[3]-ladderane-octanoyl-2-(8-[3]-ladderane-octanyl)-sn-glycerolME1098600.901.10
PI(18:0/20:4(5Z,8Z,11Z,14Z))ME1099140.851.15
PS(22:0/12:0)ME1099370.851.15
PE(O-16:0/22:5(4Z,7Z,10Z,13Z,16Z))ME1099020.831.17
PA(20:0/22:4(7Z,10Z,13Z,16Z))ME1098830.811.19
PS(19:1(9Z)/22:4(7Z,10Z,13Z,16Z))_2ME1099330.811.19
Antiarone JME109874NA1.00
Cucurbitacin JME1098780.031.83
Sulfoglycolithocholic acidME1099410.081.92
Taurocholic acid_2ME1099440.091.91
16-methyl-6Z,9Z-heptadecadienoic acidME1098630.121.88
Taurocholic acid_1ME1099430.121.88
PS(16:0/22:1(11Z))ME1099210.161.84
L-Olivosyl-oleandolideME1098820.151.85
PC(13:0/0:0)_2ME1098890.141.86
Glycocholic AcidME1098810.151.64
PS(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))ME1099360.261.74
PS(15:0/22:0)ME1099190.201.80
Taurolithocholic acidME1099450.141.75
6alpha,7alpha-Dihydroxy-3-oxo-5beta-cholan-24-oic AcidME1098710.421.58
Artonol CME1098750.381.62
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)ME1099000.351.65
PE(P-20:0/22:4(7Z,10Z,13Z,16Z))ME1099050.501.50
PE(18:2(9Z,12Z)/0:0)ME1098980.551.45
PGF2alpha_2ME1099090.531.47
Taurochenodeoxycholic acidME1099420.531.47
PS(14:0/14:0)ME1099180.661.34
PS(21:0/22:4(7Z,10Z,13Z,16Z))ME1099350.641.36
1a,1b-dihomo-15-deoxy-delta-12,14-PGJ2ME1098660.591.41
4,7,10,13,16,19-Docosahexaynoic acidME1098690.621.38
PS(19:0/22:4(7Z,10Z,13Z,16Z))_2ME1099300.611.39
PS(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))ME1099380.611.39

Factors:

F1Strain:B6.Sle1.Sle2.Sle3 (TC) | Treatment:lupus prone
F2Strain:C57BL/6J | Treatment:control
Data matrix
  logo